Piscataway, NJ, July 9, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Quetiapine Tablets, USP to its product line.
Quetiapine Tablets, USP are an atypical antipsychotic indicated for the treatment of:
-
- Schizophrenia
- Bipolar I disorder manic episodes
- Bipolar disorder, depressive episodes
Quetiapine Tablets, USP are available in:
| Strengths | Count Size(s) |
| 25 mg | 100 |
| 50 mg | 100 |
| 100 mg | 100 |
| 200 mg | 100 |
| 300 mg | 60, 100 |
| 400 mg | 100, 500 |
To learn more about Quetiapine Tablets, USP, please visit https://www.camberpharma.com/quetiapine
